目录肽产品
PTHP-005A
Hypercalcemia Malignancy Factor (1-34), human
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala
Size：0.5
P1(RMB)：766
MW：4017.7
One letter sequence：AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA
Molecular Formula：C180H287N57O48
Description：Peptide found to have anabolic effect on bone formation in rats that can inhibit the rapid decline in bone formation due to denervation.
Literature Reference：L.J. Suva et al., Science, 237, 893 (1987)
Cas：
P1(RMB)：766
MW：4017.7
One letter sequence：AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA
Molecular Formula：C180H287N57O48
Description：Peptide found to have anabolic effect on bone formation in rats that can inhibit the rapid decline in bone formation due to denervation.
Literature Reference：L.J. Suva et al., Science, 237, 893 (1987)
Cas：
